Optiscan has been featured in the Australian Trade and Investment Commission’s Medical Technology, Devices and Diagnostics Industry Capability Report, which showcases Australia’s globally competitive MedTech sector and highlights companies driving innovation across advanced manufacturing, digital health, and precision medical technologies.

The report outlines Australia’s strong MedTech ecosystem, noting the sector generates more than A$11 billion in annual revenue, exports over A$2 billion each year, and holds a significant share of global MedTech patents. It highlights the country’s strengths in precision engineering, advanced manufacturing, regulatory expertise, and research collaboration - factors positioning Australian companies for global growth.

Optiscan’s imaging technology is recognised in the report as a practical application of precision engineering in healthcare, supporting clinicians with high-resolution, real-time visualisation at the point of care. The inclusion underscores Optiscan’s role within Australia’s expanding digital health landscape and its contribution to advancing innovative medical technologies with global relevance.

Australian Trade and Investment Commission – Medical Technology, Devices and Diagnostics Industry Capability Report – View the full report here.